Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Yesintek and Yesintek I.V. are approved for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
This is the group’s first NoC approval in Canada
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Subscribe To Our Newsletter & Stay Updated
